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Talking to patients with heart
failure about end of life
Introduction
Patients with heart failure (HF), particularly
those admitted to hospital, have a reduced
life expectancy.1 When asked to consider
their preferred place for end-of-life (EOL)
care if recovery appears unlikely, many
patients express a wish to spend their final
days at home.2 Yet analysis of patients with
HF in randomized controlled trials and in
epidemiology studies suggests that most
patients with HF die in hospital.3,4 Whether
there is a discrepancy between preferred
and actual place of EOL care has not been
evaluated in a prospective cohort of patients
with HF. We aimed to address this ques-
tion, and assess the acceptability to patients
with HF (and their caregivers) of discussing
EOL care.
Methods
As part of a study assessing the palliative care
needs of a near-consecutive (i.e. consecutive
patients were enrolled except during inves-
tigator vacation or other leave), prospective
cohort of patients admitted to hospital with
HF, patients were asked to consider their
preference for place of EOL care.5,6 Specif-
ically, patients were asked to consider the
following hypothetical scenario: ‘If you were
to think about the last few days of hours
of life, would you have a strong opinion or
preference for where that care took place?’
Patients were given the following hypothetical
options to choose from: their own home;
a nursing or care home; hospital; hospice;
or undecided. Patients were followed up for
vital status and place of death using record
linkage through Information Services Divi-
sion of National Health Service, Scotland.
Comparisons of categorical variables were
performed using 𝜒2, a P-value < 0.05 was
deemed statistically significant. This study
was approved by the local ethics committee
and all patients provided written informed
consent.
Results
A total of 272 patients admitted to hospital
with HF were enrolled (Table 1) between
9 January 2013 and 1 December 2014 and
followed up for a median of 2.1 years. This
was the first HF presentation for 152 (56%)
patients and 256 of the total (94%) pro-
vided an answer to the above EOL question
(Table 2). Most expressed a wish to spend
their EOL at home. One quarter of patients
did not have a strong opinion regarding EOL
care location. The proportion of patients
with a new diagnosis answering the EOL
preference question (92%) was similar to
the proportion with an existing diagnosis
answering this question (97%). There was
no significant difference in preference for
place of EOL between those with a previous
diagnosis of HF and those with a first HF pre-
sentation, although the numbers for some of
the options were small (Table 2). The majority
in the new diagnosis group (63%) and existing
diagnosis group (60%) chose home or were
undecided (18% and 23%, respectively). Of
the 16 patients who declined to answer the
EOL question, only one patient expressed
an objection to being asked about EOL care
preferences. Overall, 103 (38%) patients died
during follow-up, with location of death avail-
able for all patients. Of these 103 deaths, 70
(68%), 18 (18%), and 15 (15%) were in hos-
pital, home, or another destination (including
hospice or care home), respectively. Loca-
tion of EOL for the 79 patients who both
expressed a preference for place of EOL and
died during follow-up is shown in Figure 1.
The distribution of place of death for these
patients, who had expressed an EOL care
preference, was similar to the overall group
which did not survive, with 55 (70%) dying
in hospital, 13 (16%) dying at home, and 11
(14%) dying at another location. Only 19 of 79
patients died in their preferred place of EOL.
Discussion
This is the first study of a prospective and
near-consecutive cohort of patients with
HF to compare preferred with actual place
of death. Our first important finding is that
patients with HF, even with a first presenta-
tion, are willing to discuss EOL care. There
was no difference in proportion of patients
willing to discuss EOL between those with
Table 1 Baseline characteristics
n 272
Age, years 76 [70–82]
Female sex 128 (47)
SBP, mmHg 134 [118–155]
NYHA class
II 82 (30)
III 141 (52)
IV 49 (18)
Previous HF diagnosis 120 (44)
Hypertension 184 (68)
Myocardial infarction 111 (41)
Atrial fibrillation 144 (53)
TIA/CVA 52 (19)
Diabetes 89 (33)
COPD 69 (25)
ICD/CRT 12 (4)
BNP, pg/mL 724 [420–1405]
eGFR, mL/min/1.73m2 62 [40–82]
Hb, g/L 122 [109–136]
EF, % 38 [25–54]
EF≥ 50% 89 (33)
Admission medications
ACEi/ARB 148 (54)
Beta-blocker 152 (56)
MRA 23 (8)
Values are expressed as n (%), or median
[interquartile range].
ACEi, angiotensin-converting enzyme inhibitor;
ARB, angiotensin receptor blocker; BNP, B-type
natriuretic peptide; COPD, chronic obstructive
pulmonary disease; CRT, cardiac resynchronization
therapy; CVA, cerebral vascular accident; EF, ejec-
tion fraction; eGFR, estimated glomerular filtra-
tion rate; Hb, haemoglobin; HF, heart failure; ICD,
implantable cardioverter defibrillator; MRA, min-
eralocorticoid receptor antagonist; NYHA, New
York Heart Association; SBP, systolic blood pres-
sure; TIA, transient ischaemic attack.
and without a prior diagnosis of HF, or the
preferred place of EOL care, suggesting these
conversations are applicable even during a
first hospitalization for HF. Only one patient
expressed concern at being asked about
EOL care. The second key finding is that we
found a major discrepancy between preferred
and actual place of EOL care. We do not
know reasons for this and clearly it is an area
for further investigation. This discrepancy
could reflect a lack of palliative care input or
resources, limited EOL communication, or
simply a disconnect between patient expecta-
tions and the reality of dying from HF. Further
research may help determine how this aspect
© 2018 The Authors. European Journal of Heart Failure published by John Wiley & Sons Ltd on behalf of European Society of Cardiology.
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Table 2 Details of answers to preferred place of end of life scenario
All patients
(n= 272)
Previous HF diagnosis
(n= 120)
First HF presentation
(n= 152)
P-value
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Provided answer to EOL scenario 256 (94) 116 (97) 140 (92) 0.11
Answer to EOL scenario
Home 157 (61) 69 (60) 88 (63) 0.05
Hospital 17 (7) 12 (10) 5 (4)
Care facility 24 (9) 6 (5) 18 (13)
Hospice 6 (2) 2 (2) 4 (3)
Undecided 52 (20) 27 (23) 25 (18)
Values are expressed as n (%).
EOL, end of life; HF, heart failure.
Figure 1 Preferred vs. actual place of death of patients who died and expressed a prefer-
ence for end-of-life (EOL) care.
of EOL care can be improved to meet patient
preferences.
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